EGFR activation limits the response of liver cancer to lenvatinib
2021; Nature Portfolio; Volume: 595; Issue: 7869 Linguagem: Inglês
10.1038/s41586-021-03741-7
ISSN1476-4687
AutoresHaojie Jin, Yao Shi, Yuanyuan Lv, Shengxian Yuan, Christel Ramirez, Cor Lieftink, Liqin Wang, Siying Wang, Cun Wang, Matheus Henrique Dias, Fleur Jochems, Yuan Yang, Astrid Bosma, E. Marielle Hijmans, Marnix H. P. de Groot, Serena Vegna, Dan Cui, Yangyang Zhou, Ling Jing, Hui Wang, Yuchen Guo, Xingling Zheng, Nikita Isima, Hai-Qiu Wu, Chong Sun, Roderick L. Beijersbergen, Leila Akkari, Weiping Zhou, Bo Zhai, Wenxin Qin, René Bernards,
Tópico(s)PI3K/AKT/mTOR signaling in cancer
Referência(s)